U.S. market Closed. Opens in 17 hours 1 minute

KALA | Kala Pharmaceuticals, Inc. Stock Financials Income Statements Annual

(Stock Exchange: NASDAQ)
*Sign In to persist settings
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-31
RevenueN/A3.89M11.24M6.36M6.07MN/AN/AN/A45.00K
Cost of Revenue303.00K2.56M4.10M3.17M2.01MN/AN/AN/AN/A
Gross Profit-303.00K1.33M7.14M3.19M4.07MN/AN/AN/AN/A
Operating Expenses38.85M82.69M116.58M99.42M92.29M64.72M39.88M32.67MN/A
Selling, General & Admin20.26M65.03M105.06M81.07M65.02M35.43M10.87M7.64M4.61M
Research & Development18.59M17.65M11.52M18.35M27.27M29.29M29.01M25.03M11.38M
Other Operating ExpensesN/A-926.00K1.31MN/AN/AN/AN/AN/AN/A
Operating Income-39.15M-81.36M-109.43M-96.23M-88.22M-64.72M-39.88M-32.67M-15.95M
Other Expenses / Income-3.05M36.53M-33.17M-8.10M-6.12M-390.00K-2.34M-498.00K-736.00K
Before Tax Income-42.20M-44.82M-142.60M-104.33M-94.35M-66.74M-42.21M-33.17M-16.68M
Income Tax ExpensesN/A-44.60M9.69M7.68M7.64M1.30MN/AN/AN/A
Net Income-42.20M-223.00K-152.30M-112.00M-101.98M-66.74M-42.21M-33.17M-16.68M
Interest Expenses-5.81M7.27M8.38M8.59M8.48M3.31M1.02M767.00K604.00K
Basic Shares Outstanding2.43M1.52M1.30M1.05M684.20K535.08K138.06K15.11M17.28M
Diluted Shares Outstanding2.43M1.52M1.30M1.05M684.20K535.08K138.06K15.11M17.28M
EBITDA-38.85M-81.62M-107.04M-95.74M-85.87M-63.03M-40.91M-32.23M-15.75M
EBITDA Margin0.00%-2,097.07%-952.34%-1,504.84%-1,413.68%0.00%0.00%0.00%-34,995.56%
EBIT-48.01M-37.56M-134.22M-95.74M-85.87M-62.13M-41.19M-32.40M-16.08M
EBIT Margin0.00%-964.95%-1,194.17%-1,504.84%-1,413.68%0.00%0.00%0.00%-35,728.89%
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-31
An error has occurred. This application may no longer respond until reloaded. Reload 🗙